Add like
Add dislike
Add to saved papers

Assessment of commercial DNA clean-up kits for elimination of qPCR inhibitors in the detection of Cyclospora cayetanensis in cilantro.

Inhibited reactions have been occasionally observed when cilantro samples were processed for the detection of Cyclospora cayetanensis using real time PCR (qPCR). Partial or total inhibition of PCR reactions, including qPCR, can occur leading to decreased sensitivity or false negative results. If inhibition occurs, this implies the need for additional purification or clean-up treatments of the extracted DNA to remove inhibitors prior to molecular detection. Our objective was to evaluate the performance of five commercial DNA clean up kits [QIAquick® Purification kit from Qiagen (#1), One step™ PCR inhibitor removal by Zymo Research (#2), Nucleospin® Genomic DNA clean up XS from Macherey-Nagel (#3), DNA IQ™ system by Promega (#4) and DNeasy® Power Plant® Pro kit from Qiagen (#5)] to minimize qPCR inhibition using the US FDA validated BAM Chapter 19b method for detection of C. cayetanensis in cilantro samples containing soil. Each of the five commercial DNA clean up kits evaluated was able to reduce the qPCR internal amplification control (IAC) C T values to those considered to be normal for non-inhibited samples, allowing unambiguous interpretation of results in cilantro samples seeded at both high oocysts level (200) and at low oocysts levels (10). Of the five kits compared, kits #1, #2 and #3 did not show significant differences in the detection of C. cayetanensis , while significant higher C T values, indicating lower recovery of the target DNA, were observed from kits #4 and/or #5 in samples seeded with 200 and 10 oocysts (p<0.05). This comparative study provides recommendations on the use of clean-up commercial kits which could be implemented when inhibition is observed in the detection of C. cayetanensis in cilantro samples using BAM Chapter 19b method.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app